Oxytetracycline is highly effective in treating infections caused by Chlamydia (e.g., the chest infection psittacosis, the eye infection trachoma, and the genital infection urethritis) and infections caused by Mycoplasma organisms (e.g., pneumonia). Oxytetracycline hydrochloride is commonly utilized as a yellow crystalline, odorless, and bitter powder. It absorbs moisture easily, darkens gradually when exposed to light, and is easily degraded in alkaline solutions.

Oxytetracycline is especially valuable in treating nonspecific urethritis, Lyme disease, brucellosis, cholera, typhus, tularaemia, and infections caused by Chlamydia, Mycoplasma, and Rickettsia. Doxycycline is often preferred to oxytetracycline for many of these indications due to its improved pharmacologic features.

Established in 2002, the enterprise is a large GMP-certified veterinary drug developer, manufacturer, and supplier. The business integrates professional R&D, large-scale production, and global sales of veterinary APIs, premium preparations, premixed feeds, and high-performance feed additives. As a recognized Technical Center, the company operates an innovated R&D system supported by 65 qualified technical professionals.

The factory manages two major production bases covering a combined area of 78,706 m², equipped with 13 advanced API production lines including Ivermectin, Eprinomectin, Tiamulin Fumarate, and Oxytetracycline Hydrochloride. It also boasts 12 preparation production lines producing high-quality injections, oral solutions, powders, premixes, boluses, pesticides, and disinfectants. OEM and ODM services are fully supported.

Strict adherence to EHS (Environment, Health & Safety) system protocols is prioritized, securing valid ISO14001 and OHSAS18001 certifications to guarantee continuous and environmentally stable production. The facility manages a complete, rigorous quality assurance system, having achieved ISO9001, GMP, Australia APVMA GMP, and Ethiopia GMP certifications, as well as passing the official US FDA inspection.

Supported by highly professional teams in registration, international sales, and technical service, the brand has gained extensive reliance and support globally through superior quality, excellent pre-sales, and prompt after-sales support. Reliable cooperation has been established with international animal pharmaceutical enterprises across Europe, South America, the Middle East, Africa, and Asia, serving over 60 countries and regions.